Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kohlmann

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Leukemia|August 21, 2013
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant diseaseA Kohlmann, N Nadarajah, T Alpermann, et al.
Blood Cancer Journal|September 4, 2012
Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemiaV Grossmann, U Bacher, A Kohlmann, et al.
Leukemia|April 30, 2010
Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathwaysA Kohlmann, L Bullinger, C Thiede, et al.
Leukemia|October 12, 2013
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patientsS Jeromin, S Weissmann, C Haferlach, et al.
Leukemia|February 6, 2009
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic featuresT Haferlach, A Kohlmann, H-U Klein, et al.
Leukemia|March 23, 2013
Landmark analysis of DNMT3A mutations in hematological malignanciesA Roller, V Grossmann, U Bacher, et al.
Leukemia|January 29, 2011
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of casesV Grossmann, A Kohlmann, M Zenger, et al.
Molecular Biology Reports|April 26, 2006
Parkin modulates gene expression in control and ceramide-treated PC12 cellsP G Unschuld, J Dächsel, F Darios, et al.
Leukemia|September 24, 2013
The role of different genetic subtypes of CEBPA mutated AMLA Fasan, C Haferlach, T Alpermann, et al.
Leukemia|July 18, 2013
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patientsS Weissmann, A Roller, S Jeromin, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Leukemia|August 21, 2013
Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant diseaseA Kohlmann, N Nadarajah, T Alpermann, et al.
Blood Cancer Journal|September 4, 2012
Expression of CEBPA is reduced in RUNX1-mutated acute myeloid leukemiaV Grossmann, U Bacher, A Kohlmann, et al.
Leukemia|April 30, 2010
Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathwaysA Kohlmann, L Bullinger, C Thiede, et al.
Leukemia|October 12, 2013
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patientsS Jeromin, S Weissmann, C Haferlach, et al.
Leukemia|February 6, 2009
AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic featuresT Haferlach, A Kohlmann, H-U Klein, et al.
Leukemia|March 23, 2013
Landmark analysis of DNMT3A mutations in hematological malignanciesA Roller, V Grossmann, U Bacher, et al.
Leukemia|January 29, 2011
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of casesV Grossmann, A Kohlmann, M Zenger, et al.
Molecular Biology Reports|April 26, 2006
Parkin modulates gene expression in control and ceramide-treated PC12 cellsP G Unschuld, J Dächsel, F Darios, et al.
Leukemia|September 24, 2013
The role of different genetic subtypes of CEBPA mutated AMLA Fasan, C Haferlach, T Alpermann, et al.
Leukemia|July 18, 2013
Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patientsS Weissmann, A Roller, S Jeromin, et al.
Pageof 5